Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2007, p. 1199-1207, Vol. 73, No. 4
0099-2240/07/$08.00+0 doi:10.1128/AEM.01834-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Department of Entomology, Cornell University, New York State Agricultural Experiment Station, Geneva, New York 14456,1 Department of Genetics, University of Valencia, Dr. Moliner 50, 46100 Burjassot (Valencia), Spain,2 Department of Zoology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada3
Received 2 August 2006/ Accepted 11 December 2006
|
|
|---|
|
|
|---|
The pathogenesis of B. thuringiensis toxins in insects involves multiple sequential steps (31). Alteration of any of the steps may affect the toxicity of B. thuringiensis toxins in insects and, consequently, can be potentially involved in B. thuringiensis resistance. Studies of B. thuringiensis resistance in insect strains that were selected with B. thuringiensis toxins in the laboratory have indeed indicated that mechanisms for B. thuringiensis resistance in insects can be complex and diverse (10, 14). Different resistant populations of the same insect species from different origins or selected in different laboratories may have distinctly different mechanisms of resistance to the same B. thuringiensis Cry toxin (1, 15, 25). Alteration of midgut proteases which are critically involved in solubilization and proteolytic processing of Cry proteins in the insect midgut has been found in several B. thuringiensis-resistant insect strains generated by laboratory selections (24, 29). Modification of midgut binding sites for B. thuringiensis toxins, which results in reduced binding of the B. thuringiensis toxins to the midgut targets, has been reported in several B. thuringiensis-resistant insect strains and appears to be a major mechanism for insect resistance to Cry1A toxins (9, 36). In addition, other B. thuringiensis resistance mechanisms have been proposed, including retention of the B. thuringiensis toxin by the midgut peritrophic membrane (16), aggregation of B. thuringiensis toxin proteins by the midgut esterase (15), elevated melanization activity of the hemolymph and midgut cells (25, 30), increased rate of repair or replacement of affected epithelial cells (26), and possibly increased antioxidation activities in B. thuringiensis-resistant insects (5). Therefore, mechanisms for B. thuringiensis resistance in insects can be multifaceted.
Studies of B. thuringiensis resistance by selection of insect populations with B. thuringiensis toxins under laboratory conditions have facilitated studies of mechanisms of B. thuringiensis resistance (11, 29), which has built the main body of the current understanding of the resistance mechanisms. However, B. thuringiensis resistance developed in field insect populations in agricultural practices may involve mechanisms different from those found from laboratory-selected resistance (2). To date, the resistance mechanisms in insects that have developed B. thuringiensis resistance in agricultural practice are not known. The cabbage looper, T. ni, has developed B. thuringiensis resistance in commercial-production greenhouses where B. thuringiensis formulations were frequently applied (20). The trait of resistance to Cry1Ac in the greenhouse T. ni population has been determined to be monogenic, autosomal, and incompletely recessive (22). In this paper, we report the characterization and identification of the biochemical mechanism for the Cry1Ac resistance evolved in a greenhouse T. ni population.
|
|
|---|
Generation of a Cry1Ac-resistant T. ni introgression strain nearly isogenic to the susceptible laboratory strain.
To introgress the Cry1Ac resistance trait from the greenhouse-derived GLEN-Cry1Ac strain to the susceptible laboratory strain, the GLEN-Cry1Ac strain was crossed with the susceptible laboratory strain and progenies in generations F2, F3, and F4 were selected by feeding on a surface-contaminated artificial diet with 4 µg Cry1Ac/cm2 (2 ml of 100-ppm Cry1Ac spread on the diet surface which is ca. 50 cm2) for F2 larvae and 20 µg Cry1Ac/cm2 (2 ml of 500-ppm Cry1Ac spread on the diet surface) for F3 and F4 larvae. The Cry1Ac-selected hybrid strain was then backcrossed with the susceptible laboratory strain, and their progenies of F2, F3, and F4 were selected again with Cry1Ac as described above. This backcross and the selection procedures were repeated. The backcross line obtained was designated GLEN-Cry1Ac-BCS, a strain nearly isogenic to the susceptible laboratory strain. The T. ni larvae used in this study were from the backcross strain after three or four backcrosses.
To confirm that the Cry1Ac resistance gene in GLEN-Cry1Ac-BCS was introgressed from the original B. thuringiensis-resistant greenhouse population, a genetic complementation analysis (38) was performed using the GLEN-Cry1Ac-BCS strain and Cry1Ac-resistant individuals from a new collection of T. ni larvae (collected in 2004) from the same greenhouse where the GLEN strain of T. ni was initially collected in 2001 (20, 22). The newly collected T. ni larvae were maintained on artificial diet without exposure to B. thuringiensis toxins for four generations, and neonate larvae from the fifth generation were placed on Cry1Ac-expressing transgenic broccoli for one generation to eliminate susceptible individuals (22). The T. ni larvae that survived on the transgenic broccoli were collected and crossed with the susceptible laboratory strain and the backcross strain GLEN-Cry1Ac-BCS. The progenies (F1) from these crosses were placed on the transgenic broccoli plants to observe their susceptibilities to the transgenic broccoli.
Bioassays.
A diet overlay assaying method was used to determine the susceptibility of T. ni larvae to Cry1Ac and other Cry toxins as described by Kain et al. (22). For neonate bioassays, an aliquot of 0.2 ml of a Cry toxin was applied to the surface (
7 cm2) of 5 ml artificial diet in a 30-ml insect-rearing cup. Each bioassay included four to six concentrations of a Cry toxin, which resulted in 10 to 90% larval mortality, and five replications for each concentration. Ten neonate larvae were placed in each assaying cup. Larval growth inhibition (defined as inhibition if larvae did not enter second instar within 4 days) by the Cry toxins was scored after 4 days of feeding on the Cry toxin-treated diet. Doses for inhibition of 50% of the individuals were calculated based on probit analysis, and statistical analyses were performed with the aid of the statistical software packages POLO and SAS as described by Kain et al. (22). The procedures for fifth-instar larva bioassays were similar to the method described for neonate bioassays, except two early-molted fifth-instar larvae were placed in a 30-ml cup with a series of concentrations of Cry1Ac overlaid on diet. Fifteen cups (30 larvae in total) were used for each Cry1Ac concentration, and larval mortalities were observed after 7 days of rearing the larvae on Cry1Ac-treated diet. The sources of B. thuringiensis Cry toxins used for the bioassays were the same as described earlier by Zhao et al. (43), except that Cry1Ac was prepared from B. thuringiensis subsp. kurstaki strain HD-73 (22) and Cry1Ab toxin was purified from inclusion bodies produced in the Escherichia coli PBD-140 strain (Ruud A. de Maagd, Plant Research International B.V., Wageningen, The Netherlands). To prepare Cry1Ab, E. coli PBD-140 was cultured at 37°C in TB medium (17 mM KH2PO4, 72 mM K2HPO4, 10.8 g/liter tryptone, 21.6 g/liter yeast extract, 0.36% glycerol), supplemented with 50 µg/ml of ampicillin. The E. coli was harvested by centrifugation and stored at 20°C after lyophilization. For isolation of Cry1Ab inclusion bodies, a 1-g E. coli pellet was dissolved in a lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 100 mM NaCl, 25 µg/ml lysozyme) at room temperature for 20 min with gentle shaking, followed by addition of 16 mg deoxycholic acid and another incubation for 10 min at 37°C. Then, 0.8 mg DNase I was added, and the incubation was continued for an additional 30 min at 37°C with vigorous shaking. The inclusion bodies of the protoxin were pelleted by centrifugation at 40,000 x g for 10 min, followed by two washes with washing buffer (20 mM Tris-HCl, pH 7.5, 1% Triton X-100, 1 M NaCl) and a final wash with phosphate-buffered saline (PBS; 1 mM KH2PO4, 10 mM Na2HPO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4). The purified inclusion bodies were solubilized by incubation in the solubilization buffer (50 mM sodium carbonate, pH 10, 100 mM NaCl, 10 mM dithiothreitol) for 1 h at 37°C with constant shaking, and solubilized protoxin was recovered in the supernatant after centrifugation at 40,000 x g for 15 min.
Hemolymph melanization assays.
To examine whether hemolymph melanization activity is elevated in the resistant larvae, in vitro hemolymph plasma melanization assays were conducted in accordance with the method described by Rahman et al. (30). Forty microliters of larval hemolymph was collected from a proleg of a fifth-instar larva and immediately diluted in 200 µl ice-cold PBS. Hemocytes were removed by centrifugation at 16,000 x g for 4 min. One hundred microliters of the resulting supernatant was mixed in 100 µl of PBS in a 96-well microtiter plate, and the optical density of the hemolymph plasma suspension was recorded with a microtiter plate reader at 490 nm for 90 min to determine the kinetics of the melanization reaction.
Midgut protease activity assays.
Mid-fifth-instar larvae were immobilized on ice for several minutes and dissected to isolate the complete midgut without loss of its contents. The isolated midgut was weighed and individually stored at 20°C. Midgut homogenates were prepared by thorough homogenization of the midgut in a 1.5-ml microcentrifuge tube and suspended in deionized water to constitute a 10% (wt/vol) suspension.
Total protease activity of the midgut was determined at pH 8 and pH 11 using azocasein (Sigma, St. Louis, MO) as the substrate as described by Broadway (4). Briefly, 50 µl of midgut homogenate was mixed with 150 µl 1% azocasein in 50 mM Tris-HCl buffer (pH 8) or 20 µl of midgut homogenate was mixed with 150 µl 1% azocasein in 50 mM NaHCO3-Na2CO3 buffer (pH 11) and incubated at 28°C for 2 h. The digestion was stopped, and undigested azocasein was precipitated by addition of an equal volume of 10% trichloroacetic acid, followed by incubation at room temperature for 1 h. The precipitated proteins were removed by centrifugation at 16,000 x g for 10 min. The supernatant was collected, and its optical absorbance at 450 nm was measured after mixing with an equal volume of 1 M NaOH.
Midgut elastase activity was assayed with N-succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide (Suc-Ala3-pNA; Sigma) as a chromogenic substrate. For activity assays at pH 8.0, 20 µl of midgut homogenate was mixed with 480 µl of 50 mM Tris-HCl buffer (pH 8.0) and 10 µl of 55 mM Suc-Ala3-pNA. For assays at pH 11, 10 µl of midgut homogenate was mixed with 490 µl of 50 mM NaHCO3-Na2CO3 buffer (pH 11) and 10 µl of 55 mM Suc-Ala3-pNA. The peptidolytic reaction was immediately monitored by recording the increase of optical absorbance at 410 nm at 28°C for 60 min. Trypsin activity in the midgut homogenate was determined by mixing 10 µl of midgut homogenate in 3 ml of 1 mM Na-benzoyl-L-arginine p-nitroanilide (BApNA; Sigma) in 50 mM Tris-HCl (pH 8.0) or by mixing 3 µl of midgut homogenate in 3 ml of 1 mM BApNA in 50 mM NaHCO3-Na2CO3 buffer (pH 11). The enzymatic reaction at 28°C was monitored by recording the optical absorbance at 405 nm for 60 min. Determination of chymotrypsin activity in the midgut homogenates was similar to the method used for the trypsin assays except 1 mM N-succinyl-Ala-Ala-Pro-phenylalanine p-nitroanilide (Sigma) was used as the substrate and 3 µl of 10-fold-diluted midgut homogenate was used for the assays. Aminopeptidase activity in the midgut homogenate was determined using leucine p-nitroanilide (Sigma) as the chromogenic substrate as described by Wang et al. (40). For all the protease assays, samples from five larvae for each strain were individually assayed and the activity for each sample was calculated using the data points in the linear portion of the initial reaction curve, followed by statistical significance analysis.
Zymogram analysis of midgut proteinases.
Midgut protease zymogram analysis was performed using the method developed by Garcia-Carreno et al. (12) with modifications. Briefly, 1 µl of 10% midgut homogenate was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis with a 12.5% SDS-PAGE gel to separate the midgut proteins, followed by a washing of the gel with 2% Triton X-100 for 15 min to remove the SDS from the gel. The gel was then incubated with 2% casein (Sigma) in 50 mM Tris-HCl (pH 8.0) for 3 h at room temperature, followed by Coomassie blue staining after a brief rinse of the gel with deionized water to visualize the protease activities in the gel.
Digestion of Cry1Ac protoxin with T. ni larval midgut fluid.
T. ni larval midgut fluid from both susceptible and resistant larvae was collected from fifth-instar larvae by stimulating the larval mouth parts to induce regurgitation. A 10-µl aliquot of Cry1Ac protoxin (5 µg/µl) was mixed with 10 µl of midgut fluid solution in a series of dilutions in 50 mM NaHCO3-Na2CO3 buffer (pH 10.5) and incubated at 26°C for 60 min. The incubation was stopped by addition of 20 µl 2x SDS-PAGE sample buffer followed by heating at 100°C for 5 min. The digestion of Cry1Ac protoxin for conversion to active toxin by midgut fluid was examined by SDS-PAGE analysis, followed by Coomassie blue staining.
Midgut esterase analysis.
Midgut esterases in the resistant and susceptible T. ni larvae were comparatively analyzed by total-activity assays and isozyme profile analysis. Midgut extracts were prepared as described above for midgut protease analysis except that the midgut tissue was homogenized in 0.1% Triton X-100. The midgut homogenates were then clarified by centrifugation at 16,000 x g for 10 min, and the supernatants were collected for esterase analysis. Esterase activities were determined by mixing 5 µl midgut extract in 3 ml reaction solution containing 2.5 mg/ml of Fast Blue RR and 0.1 mg/ml
-naphthyl acetate (Sigma) in 0.1 M sodium phosphate buffer (pH 6.5), followed by monitoring the increase of optical absorbance at a wavelength of 450 nm for 5 min at 26°C (33). The enzymatic activities were calculated as units of optical absorbance increase per minute using the linear part of the recorded reaction curve.
For midgut esterase isozyme profiling, proteins from 10 µl of midgut extract were separated by 7% PAGE, followed by two washings of the gel with 0.1 M sodium phosphate buffer (pH 6.5) for 10 min. The esterase isozyme activities in the gels were visualized by incubation in the reaction solution containing 0.75 mg/ml of Fast Blue RR and 0.2 mg/ml of
-naphthyl acetate in 0.1 M sodium phosphate buffer (pH 6.5). The colorimetric reaction was stopped by fixation of the gel in 5% acetic acid and 10% methanol.
Preparation of midgut BBMVs.
Midgut brush border membrane vesicle (BBMV) preparations were made from the susceptible and resistant strains and the progeny (F1) from the cross of the susceptible (female) and resistant (male) strains. Mid-fifth-instar larvae were immobilized on ice for several min and dissected in cold MET buffer (250 mM mannitol, 17 mM Tris-HCl, 5 mM EGTA, pH 7.5) to isolate the midgut epithelium, free of any attached tissues (fat body and Malpighian tubules), and the peritrophic membrane with food contents. The isolated midgut epithelium was thoroughly rinsed with cold MET buffer and quickly frozen in liquid nitrogen after removal of excess buffer from the dissected tissue. The frozen midgut tissues were shipped on dry ice from Cornell University to the University of Valencia and stored at 80°C before use. Midgut BBMVs were prepared by the differential-magnesium-precipitation method (41) and stored at 80°C after being frozen in liquid nitrogen. BBMV preparations were quantified by the BBMV protein concentration determined with the Bradford method (3).
BBMV-associated aminopeptidase and alkaline phosphatase activities were determined using an aliquot of each BBMV preparation containing 200 ng proteins. Alkaline phosphatase activity was determined using the alkaline phosphatase (DEA) kit from Biosystems (Barcelona, Spain) by following the manufacturer's instructions. Leucine aminopeptidase activity was measured using L-leucil-ß-naphthylamide as the substrate as described by Hernández et al. (17).
Preparation, purification, and labeling of Cry1Ac and Cry1Ab for binding analysis.
Cry1Ac toxin was purified from a recombinant B. thuringiensis strain (EG11070) as described by Estela et al. (7). Cry1Ab was prepared as described above. Activated Cry toxins were prepared by digestion with trypsin, followed by dialysis overnight against 20 mM Tris-HCl buffer (pH 8.6) and finally purified by ion-exchange chromatography as described by Estela et al. (7). The purity and quantity of the toxins were examined by SDS-PAGE analysis and consequent densitometric analysis of the toxin protein bands in the gel using bovine serum albumin as a standard. To label the Cry1Ac and Cry1Ab with 125I, 20 µg of each toxin was incubated with 0.25 mCi of Na125I (Nucliber, Madrid, Spain) using chloramine-T (Sigma) as described by Van Rie et al. (39). The specific radioactivities obtained were 110 and 5.1 mCi/mg protein for Cry1Ac and Cry1Ab, respectively.
Binding of 125I-labeled Cry1Ac and Cry1Ab to T. ni midgut BBMVs.
Qualitative binding experiments were performed as previously described by Estada and Ferré (6). Increasing concentrations of BBMV were incubated with 6.3 pM of 125I-Cry1Ac or 130 pM of 125I-Cry1Ab in 0.1 ml binding buffer (PBS-0.1% bovine serum albumin) for 1 h. The BBMVs were then pelleted by centrifugation at 16,000 x g for 10 min and washed twice with binding buffer. The final radioactivity remaining in the BBMV pellets was measured in a 1282 Compugamma CS gamma counter (LKB, Pharmacia). Nonspecific binding was determined in the presence of an excess of unlabeled protein (300 nM). The nonspecific binding of Cry1Ac and Cry1Ab to the BBMVs from the susceptible and F1 larvae accounted for 11.4% and 8.0% and 6.4% and 10.5%, respectively, of the total radioactivity used in the assay. The amount of specific binding was calculated by subtraction of nonspecific binding from the total binding, and the binding experiments were replicated at least twice.
Quantitative binding analysis was performed with BBMVs from susceptible and F1 insects, by means of homologous competition with Cry1Ac. BBMVs (0.05 mg/ml) and a fixed amount of 125I-labeled Cry1Ac were incubated with increasing concentrations of unlabeled Cry1Ac. Data were analyzed with the LIGAND computer program (28).
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Resistance of T. ni GLEN-Cry1Ac-BCS strain to Cry1Ac protoxin
|
|
View this table: [in a new window] |
TABLE 2. Survival of T. ni larvae from different strains on Cry1Ac-expressing transgenic broccoli plants
|
Pattern of cross-resistance of T. ni GLEN-Cry1Ac-BCS larvae to various B. thuringiensis Cry toxins.
Comparative bioassays of neonate larvae of the GLEN-Cry1Ac-BCS strain and its nearly isogenic susceptible strain for their susceptibilities to 11 Cry toxins showed that the GLEN-Cry1Ac-BCS larvae were highly resistant to Cry1Ab and Cry1Ac, with resistance levels of 938- and 870-fold, respectively, and were moderately resistant to Cry1Aa, Cry1E, and Cry1F, with resistance levels ranging from 6.7- to 8.2-fold (Table 3). The GLEN-Cry1Ac-BCS larvae also exhibited reduced susceptibilities to the rest of the tested Cry toxins, but the levels of resistance, ranging from two- to threefold, were minimal or statistically insignificant. This cross-resistance pattern is in agreement with the known pattern of Cry toxin binding to their shared midgut binding sites in T. ni (6, 19).
|
View this table: [in a new window] |
TABLE 3. Resistance of GLEN-Cry1Ac-BCS larvae to different B. thuringiensis Cry protoxins
|
![]() View larger version (19K): [in a new window] |
FIG. 1. In vitro melanization activity of hemolymph plasma from the susceptible and resistant larvae. Error bars indicate 95% confidence intervals of the means from three replications.
|
![]() View larger version (23K): [in a new window] |
FIG. 2. Midgut protease activities from T. ni larvae from the susceptible and GLEN-Cry1Ac-BCS strains. Protease activities are presented as relative activities (the activities from the susceptible strain are presented as 100%). Error bars indicate the 95% confidence intervals for the means from five replications. S and R represent susceptible and resistant larvae, respectively. The pH values indicate the pHs in which the enzymatic activities were assayed.
|
![]() View larger version (63K): [in a new window] |
FIG. 3. SDS-PAGE gel showing in vitro digestion of Cry1Ac protoxin by diluted T. ni larval midgut fluid from the susceptible and GLEN-Cry1Ac-BCS strains. Lanes: 1 and 2, 10% larval gut fluid from susceptible and GLEN-Cry1Ac-BCS strains, respectively; 3 to 7, Cry1Ac protoxin incubated with 10%, 1%, 0.1%, 0.01%, and 0.001% gut fluid, respectively, from susceptible larvae; 8 to 12, Cry1Ac protoxin incubated with 10%, 1%, 0.1%, 0.01%, and 0.001% gut fluid, respectively, from GLEN-Cry1Ac-BCS larvae; 13, Cry1Ac protoxin control.
|
![]() View larger version (51K): [in a new window] |
FIG. 4. SDS-PAGE zymograms of larval midgut proteases from the susceptible, GLEN-Cry1Ac, and GLEN-Cry1Ac-BCS strains. Five individual larvae were analyzed in each group.
|
The midgut esterase isozyme profiles showed four or five major esterase isozymes in the T. ni midgut. Similar to the intrastrain variations in total esterase activities, intraspecific variation of esterase isozyme composition was also observed (Fig. 5). Both the susceptible and resistant larvae showed two types of esterase isozyme gel profiles. Clearly, the observed variation in esterase isozyme composition in the larvae does not correlate with the resistance.
![]() View larger version (121K): [in a new window] |
FIG. 5. Midgut esterase isozyme profiles of T. ni larvae from the susceptible and GLEN-Cry1Ac-BCS strains. Five individual larvae were analyzed for each strain.
|
Determination of the binding of 125I-labeled Cry1Ab and Cry1Ac to BBMVs from the susceptible, resistant, and F1 T. ni larvae showed that the binding of 125I-Cry1Ac to the BBMVs from susceptible and F1 larvae increased linearly with increasing concentrations of BBMVs within the range of concentrations tested, reaching maximum specific binding levels of 22% and 18.1%, respectively, at the highest concentration of BBMVs tested (Fig. 6). In contrast, the same binding assay using BBMVs from resistant insects did not show any specific binding of 125I-Cry1Ac. Similarly, no specific binding of 125I-Cry1Ab to the BBMVs from resistant larvae was detected, although 125I-Cry1Ab bound to the BBMVs from the susceptible and F1 larvae specifically with maxima of 3% and 1.6%, respectively (Fig. 6). Therefore, the midgut BBMVs from the resistant larvae lack specific affinity for binding to Cry1Ab and Cry1Ac.
![]() View larger version (19K): [in a new window] |
FIG. 6. Specific binding of 125I-Cry1Ac and 125I-Cry1Ab as a function of midgut BBMV concentration from susceptible (), resistant ( ), and F1 ( ) larvae. Each data point represents the mean of two replicates. Error bars indicate standard deviations of the data points.
|
![]() View larger version (19K): [in a new window] |
FIG. 7. Competitive binding of 125I-Cry1Ac to midgut BBMVs from susceptible () and F1 ( ) larvae in the presence of nonlabeled Cry1Ac. Each data point represents the mean of two replicates. Error bars indicate standard deviations of the data points.
|
|
|
|---|
With the nearly isogenic resistant and susceptible T. ni strains, two approaches were taken to examine the involvement of the midgut binding to the Cry toxins: characterization of the pattern of cross-resistance of Cry1Ac-resistant T. ni to various Cry toxins and direct determination of specific binding of the toxins to the midgut BBMVs. The results from both approaches indicated that Cry1Ac resistance in T. ni is conferred by loss of affinity for midgut binding to the Cry1Ac toxin. It is known that Cry1Ab and Cry1Ac share the same high-affinity binding site in the T. ni midgut and that Cry1Aa and Cry1F also bind to the Cry1Ab/Cry1Ac shared binding site with a low binding affinity (6, 19). The pattern of cross-resistance of GLEN-Cry1Ac-BCS larvae to 11 tested Cry toxins (Table 3) showed that the levels of resistance to the Cry toxins in the resistant T. ni larvae correlated with the lack of the Cry1Ab/Cry1Ac shared binding site in the larvae. Consistently, the direct binding analysis demonstrated that the midgut BBMV preparation from the resistant T. ni larvae lacked affinity for binding to Cry1Ab/Cry1Ac. Moreover, the F1 larvae from the cross of the susceptible and resistant parents, which were susceptible to Cry1Ac, exhibited affinity for midgut binding to the toxins, further confirming that loss of the Cry1Ab/Cry1Ac binding affinity in the larval midgut is the mechanism conferring the resistance.
Current understanding of B. thuringiensis resistance in insects has indicated that mechanisms for B. thuringiensis resistance can be diverse and complex and that a resistant strain may have multiple resistance mechanisms (10, 13, 14, 18, 21). Therefore, it is necessary to examine all possible mechanisms for B. thuringiensis resistance in the greenhouse-evolved T. ni populations, in addition to binding of B. thuringiensis toxins to the midgut. Results in this study showed that heightened insect immune response, as determined by measuring hemolymph melanization activity, and increased midgut esterase production are not the mechanism for Cry1Ac resistance in the T. ni greenhouse population (Fig. 1 and 5). Differential midgut protease compositions, profiled by zymogram analysis, between the greenhouse-originated T. ni larvae (GLEN-Cry1Ac) and the laboratory susceptible larvae were observed. However, this difference arose from the different genetic backgrounds of the two strains but was not associated with Cry1Ac resistance (Fig. 4). In agreement with the midgut protease zymogram analysis, no significant difference was observed in larval midgut protease activities between the resistant and susceptible strains (Fig. 2). Furthermore, the results from in vitro activation of Cry1Ac protoxin and degradation of activated Cry1Ac toxin by the larval midgut digestive fluid also indicated that alteration of midgut proteases is not the mechanism of Cry1Ac resistance in the greenhouse-evolved B. thuringiensis-resistant T. ni population (Fig. 3). Therefore, it is clear that the mechanism for greenhouse-evolved Cry1Ab/Cry1Ac resistance resulted from the loss of affinity for the binding of the midgut epithelium to the toxins Cry1Ab and Cry1Ac. Notably, a previously reported Cry1Ab-resistant T. ni strain obtained by laboratory selection did not exhibit cross-resistance to Cry1Ac regardless of the fact that the Cry1Ab and Cry1Ac share the same binding sites (6). This observation demonstrates that field-evolved resistance may involve a mechanism different from laboratory-selected resistance.
Results from this study showed that the loss of affinity for the binding of the midgut to Cry1Ab/Cry1Ac is inherited as a recessive trait, which is in agreement with the recessive inheritance that we have previously observed for the resistance trait (22) and consistent with a loss-of-function mechanism. Reduced binding of Cry toxins to the midgut brush border membranes has been observed in a number of insect species with high levels of resistance to Cry1A toxins (9, 18). Suggested midgut receptors for Cry1A include the midgut cell membrane proteins cadherin, aminopeptidase N, alkaline phosphatase, and a 252-kDa high-molecular-weight protein and midgut glycolipids. The loss of binding sites in the insect larval midgut could be due to the absence of the midgut cadherin as a result of premature truncation of the cadherin gene transcript or mutations in the Cry toxin binding sites in the cadherin sequences (11, 27, 42). However, in Cry1Ac-resistant diamondback moth strains originated from field-developed resistant populations from two geographical regions, the reduced binding of Cry1A toxins is not conferred by cadherin gene mutations (2). In this study, it became clear that the Cry1Ac resistance in the greenhouse T. ni population is conferred by alteration of the larval midgut binding to the Cry toxins. What serves as the receptor for the Cry1Ab and Cry1Ac in T. ni larvae and what alteration has occurred to the receptor in the resistant population require further investigation in order to understand the molecular genetic basis for the greenhouse-evolved resistance in T. ni populations.
Published ahead of print on 22 December 2006. ![]()
|
|
|---|
-endotoxin of Bacillus thuringiensis in the cotton bollworm, Helicoverpa armigera (Lepidoptera: Noctuidae). J. Econ. Entomol. 96:1290-1299.[Medline]
-endotoxins. Importance of specific receptors on the brush border membrane of the midgut of target insects. Eur. J. Biochem. 186:239-247.[Medline]
-endotoxin of Bacillus thuringiensis in Helicoverpa armigera. Appl. Environ. Microbiol. 71:948-954.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»